< Back to previous page
Patent
Design synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity
The present invention is directed to compounds, methods and compositions for treating or preventing viral infections using nucleosides analogs. Specifically, the present invention provides for the design and synthesis of acyclic fleximer nucleoside analogues having increased flexibility and ability to alter their conformation structures to provide increased antiviral activity potential with the result of inhibiting several coronaviruses.
Patent Publication Number: EP3250564
Year filing: 2021
Year approval: 2021
Year publication: 2021
Status: Assigned
URI: link to Espacenet
Technology domains: Pharmaceuticals
Validated for IOF-key: Yes
Attributed to: Associatie KULeuven